David Pickar - Concepedia

Author

David Pickar

Also Known As

D Pickar, DAVID PICKAR, David Pickar, David Pickar, MD, there have been relatively few studies of this finding with respect to genetic variation or brain development. Similarly

180

Publications

8.4K

Citations

H-Index

115

Concepts

All Affiliations

National Institute of Mental Health National Institutes of Health National Institute of Mental Health University of Maryland, Baltimore National Institute on Alcohol Abuse and Alcoholism

About

David Pickar is an author at National Institute of Mental Health specializing in medicine, psychiatry, and social sciences.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	39	79	4.4K
2	Social Sciences	30	51	3.5K
3	Health Sciences	17	17	780
4	Anesthesia	4	4	190
5	Allergy	1	1	41

David Pickar

Publications

7.4K

Citations

H-Index

Page 1

	Year	Citations
Responses to Corticotropin-Releasing Hormone in the Hypercortisolism of Depression and Cushing's Disease Philip W. Gold, D. Lynn Loriaux, Alec Roy, New England Journal of Medicine	1986	771
Comparison of Ketamine-Induced Thought Disorder in Healthy Volunteers and Thought Disorder in Schizophrenia Caleb M. Adler, Anil K. Malhotra, Igor Elman, American Journal of Psychiatry	1999	338
Longitudinal Measurement of Plasma Homovanillic Acid Levels in Schizophrenic Patients David Pickar Archives of General Psychiatry	1986	318
Effects of Ketamine on Thought Disorder, Working Memory, and Semantic Memory in Healthy Volunteers Calebm. Adler, TerryE. Goldberg, AnilK. Malhotra, Biological Psychiatry Cognitive ScienceBrain FunctionHealthy VolunteersPsychopharmacologyWorking Memory	1998	306
The Effect of Clozapine on Cognition and Psychiatric Symptoms in Patients with Schizophrenia Terry E. Goldberg, Richard D. Greenberg, Suzanne Griffin, The British Journal of Psychiatry NeuropsychologyPsychiatric SymptomsPsychotropic MedicationPsychopharmacologyNeuropsychiatry	1993	293
Neuroleptic-Induced Decrease in Plasma Homovanillic Acid and Antipsychotic Activity in Schizophrenic Patients David Pickar, Rodrigo Labarca, Markku Linnoila, Science Psychotropic MedicationPlasma-free Homovanillic AcidPsychopharmacologyNeuropsychiatryEpilepsy	1984	245
Quantification of Amphetamine-Induced Changes in [<sup>11</sup>C]Raclopride Binding with Continuous Infusion Richard E. Carson, Alan Breier, Andrea de Bartolomeis, Journal of Cerebral Blood Flow & Metabolism PsychopharmacologySingle BolusPharmacotherapyExperimental PharmacologySocial Sciences	1997	240
Clozapine and Risperidone in Chronic Schizophrenia: Effects on Symptoms, Parkinsonian Side Effects, and Neuroendocrine Response Alan Breier, Anil K. Malhotra, Tung‐Ping Su, American Journal of Psychiatry	1999	206
Effects of NMDA antagonism on striatal dopamine release in healthy subjects: Application of a novel PET approach Alan Breier, Caleb M. Adler, Neil Weisenfeld, Synapse	1998	198
Positron Emission Tomography in Schizophrenic Patients with and without Neuroleptic Medication Lynn E. DeLisi, Henry H. Holcomb, Robert M. Cohen, Journal of Cerebral Blood Flow & Metabolism Schizophrenic PatientsNeuropsychologyPsychotropic MedicationTotal Brain CortexPsychopharmacology	1985	172

Page 1